Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a ...
Priests and nuns joined thousands along Metro Manila’s main highway, EDSA, to commemorate the 1986 ... the Church will continue to do so,” said Cardinal Pablo Virgilio David of Kalookan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback